2193-6536

Neurology and Therapy

Springer-Verlag

View prefix report (10.1007)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 983 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact983 DOIs
2

Attach ORCID iDs across 383 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact383 DOIs
3

Add license metadata to 88 records

License metadata tells indexers and readers how each article may be reused.

Low impact88 DOIs

DOIs for this ISSN

Showing the top 5 of 982 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Vitamin D and Multiple Sclerosis: A Comprehensive Review (10.1007/s40120-017-0086-4)
Abstract ORCID License
193.14 375
2 A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving… (10.1007/s40120-017-0073-9)
Abstract ORCID License
178.11 236
3 Mechanism of Action and Clinical Application of Tafamidis in… (10.1007/s40120-016-0040-x)
Abstract ORCID License
166.90 167
4 Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers… (10.1007/s40120-017-0074-8)
Abstract ORCID License
150.00 99
5 The Impact of Red Blood Cell Distribution Width and Neutroph… (10.1007/s40120-015-0039-8)
Abstract ORCID License
149.67 98
6 Increasing Precision of Clinical Diagnosis of Alzheimer's Di… (10.1007/s40120-017-0069-5)
Abstract ORCID License
148.33 94
7 Pregnancy Outcomes Following Maternal and Paternal Exposure… (10.1007/s40120-014-0020-y)
Abstract ORCID License
147.98 93
8 Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical… (10.1007/s40120-015-0033-1)
Abstract ORCID License
142.73 79
9 Comparative Effectiveness Research of Disease-Modifying Ther… (10.1007/s40120-017-0064-x)
Abstract ORCID License
140.63 74
10 Virtual Reality Versus Conventional Treatment of Reaching Ab… (10.1007/s40120-012-0003-9)
Abstract ORCID License
140.19 73
11 A Review of Tafamidis for the Treatment of Transthyretin-Rel… (10.1007/s40120-015-0031-3)
Abstract ORCID License
137.91 68
12 Detection of Plasma Biomarkers Using Immunomagnetic Reductio… (10.1007/s40120-017-0075-7)
Abstract ORCID License
137.44 67
13 Depression Among HIV/AIDS Patients on Highly Active Antiretr… (10.1007/s40120-017-0065-9)
Abstract ORCID License
135.97 64
14 A Review of the Social, Psychological, and Economic Burdens… (10.1007/s40120-013-0007-0)
Abstract ORCID License
128.70 51
15 Natalizumab Discontinuation and Treatment Strategies in Pati… (10.1007/s40120-015-0038-9)
Abstract ORCID License
126.09 47
16 Use of Prazosin for Pediatric PTSD-Associated Nightmares and… (10.1007/s40120-017-0078-4)
Abstract ORCID License
120.15 39
17 A Review of Biomarkers for Neurodegenerative Disease: Will T… (10.1007/s40120-017-0072-x)
Abstract ORCID License
118.48 37
18 Epilepsy: Knowledge, Attitude, and Practice Among Secondary… (10.1007/s40120-017-0083-7)
Abstract ORCID License
118.48 37
19 Consensus Management of Gastrointestinal Events Associated w… (10.1007/s40120-015-0037-x)
Abstract ORCID License
116.72 35
20 Chronic Treatment with the 5-HT1A Receptor Partial Agonist T… (10.1007/s40120-013-0015-0)
Abstract ORCID License
115.81 34
21 Sustained Effect of Delayed-Release Dimethyl Fumarate in New… (10.1007/s40120-016-0042-8)
Abstract ORCID License
115.81 34
22 Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®)… (10.1007/s40120-014-0018-5)
Abstract ORCID License
113.89 32
23 Florbetaben for PET Imaging of Beta-Amyloid Plaques in the B… (10.1007/s40120-014-0022-9)
Abstract ORCID License
113.89 32
24 Neuropsychiatric Adverse Reactions to Mefloquine: a Systemat… (10.1007/s40120-016-0045-5)
Abstract ORCID License
113.89 32
25 Quality of Life in Depressed Patients in UK Primary Care: Th… (10.1007/s40120-013-0006-1)
Abstract ORCID License
110.78 29
26 Deep Learning and Neurology: A Systematic Review (10.1007/s40120-019-00153-8)
Abstract ORCID
108.22 145
27 Post Hoc Analysis of Nutritional Status in Patients with Tra… (10.1007/s40120-014-0023-8)
Abstract ORCID License
107.35 26
28 Patient Satisfaction with the New Interferon Beta-1b Autoinj… (10.1007/s40120-015-0036-y)
Abstract ORCID License
107.35 26
29 High-Risk PML Patients Switching from Natalizumab to Alemtuz… (10.1007/s40120-016-0058-0)
Abstract ORCID License
107.35 26
30 Medication Therapy Management Service for Patients with Park… (10.1007/s40120-016-0046-4)
Abstract ORCID License
106.12 25
31 Neurophysiological Markers of Alzheimer’s Disease: Quantitat… (10.1007/s40120-019-00169-0)
Abstract ORCID
105.36 127
32 Perspectives from the Patient and the Healthcare Professiona… (10.1007/s40120-017-0088-2)
Abstract ORCID License
104.85 24
33 Fingolimod Rebound: A Review of the Clinical Experience and… (10.1007/s40120-019-00160-9)
Abstract ORCID
104.50 122
34 A Prospective Study of Patients with Brain MRI Showing Incid… (10.1007/s40120-014-0024-7)
Abstract ORCID License
103.52 23
35 Current Data on and Clinical Insights into the Treatment of… (10.1007/s40120-016-0050-8)
Abstract ORCID License
103.52 23
36 Multiple Sclerosis in Pediatrics: Current Concepts and Treat… (10.1007/s40120-016-0052-6)
Abstract ORCID License
102.13 22
37 Treatment of Adults with Lennox–Gastaut Syndrome: Further An… (10.1007/s40120-016-0041-9)
Abstract ORCID License
100.68 21
38 Diagnosing and Treating Depression in Patients with Alzheime… (10.1007/s40120-019-00148-5)
Abstract ORCID
99.34 96
39 Effectiveness and Safety of Dimethyl Fumarate Treatment in R… (10.1007/s40120-017-0080-x)
Abstract ORCID License
99.17 20
40 Perspectives from the Patient and the Healthcare Professiona… (10.1007/s40120-017-0087-3)
Abstract ORCID License
97.58 19
41 The Impact of Spina Bifida on Caregivers (10.1007/s40120-012-0004-8)
Abstract ORCID License
95.91 18
42 Survey of US Patients with Multiple Sclerosis: Comparison of… (10.1007/s40120-016-0047-3)
Abstract ORCID License
95.91 18
43 Salivary Biomarkers for Alzheimer’s Disease and Related Diso… (10.1007/s40120-019-00168-1)
Abstract ORCID
95.69 81
44 Evaluation of Quality of Life in Patients With Narcolepsy Tr… (10.1007/s40120-016-0053-5)
Abstract ORCID License
94.15 17
45 Prescription Patterns of Medications for Alzheimer’s Disease… (10.1007/s40120-016-0057-1)
Abstract ORCID License
94.15 17
46 Post-COVID-19 Syndrome is Rarely Associated with Damage of t… (10.1007/s40120-022-00395-z)
Abstract ORCID
92.25 69
47 The Lived Experience of Myasthenia Gravis: A Patient-Led Ana… (10.1007/s40120-021-00285-w)
Abstract ORCID
91.63 67
48 Burden of Migraine in Europe Using Self-Reported Digital Dia… (10.1007/s40120-018-0113-0)
Abstract ORCID
90.98 65
49 Perampanel: What is its Place in the Management of Partial O… (10.1007/s40120-013-0012-3)
Abstract ORCID License
90.31 15
50 A Case Report of Solitary Sclerosis: This is Really Multiple… (10.1007/s40120-017-0082-8)
Abstract ORCID License
90.31 15